| Sentinel lymph node mapping and staging in endometrial cancer: a Society of Gynecologic Oncology literature review with consensus recommendations RW Holloway, NR Abu-Rustum, FJ Backes, JF Boggess, WH Gotlieb, ... Gynecologic oncology 146 (2), 405-415, 2017 | 390 | 2017 |
| Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis AJB Smith, AN Fader, EJ Tanner American journal of obstetrics and gynecology 216 (5), 459-476. e10, 2017 | 339 | 2017 |
| Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers Y Wang, L Li, C Douville, JD Cohen, TT Yen, I Kinde, K Sundfelt, SK Kjær, ... Science translational medicine 10 (433), eaap8793, 2018 | 211 | 2018 |
| A comparison of colorimetric versus fluorometric sentinel lymph node mapping during robotic surgery for endometrial cancer AK Sinno, AN Fader, KL Roche, RL Giuntoli II, EJ Tanner Gynecologic oncology 134 (2), 281-286, 2014 | 169 | 2014 |
| FTO-Dependent N6-Methyladenosine Modifications Inhibit Ovarian Cancer Stem Cell Self-Renewal by Blocking cAMP Signaling H Huang, Y Wang, M Kandpal, G Zhao, H Cardenas, Y Ji, A Chaparala, ... Cancer research 80 (16), 3200-3214, 2020 | 149 | 2020 |
| Lymphopenia and its association with survival in patients with locally advanced cervical cancer ES Wu, T Oduyebo, LP Cobb, D Cholakian, X Kong, AN Fader, ... Gynecologic oncology 140 (1), 76-82, 2016 | 146 | 2016 |
| Factors associated with successful bilateral sentinel lymph node mapping in endometrial cancer EJ Tanner, AK Sinno, RL Stone, KL Levinson, KC Long, AN Fader Gynecologic oncology 138 (3), 542-547, 2015 | 138 | 2015 |
| Frizzled-7 identifies platinum-tolerant ovarian cancer cells susceptible to ferroptosis Y Wang, G Zhao, S Condello, H Huang, H Cardenas, EJ Tanner, JJ Wei, ... Cancer research 81 (2), 384-399, 2021 | 137 | 2021 |
| NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021: Featured Updates to the NCCN Guidelines NR Abu-Rustum, CM Yashar, K Bradley, SM Campos, J Chino, HS Chon, ... Journal of the National Comprehensive Cancer Network 19 (8), 888-895, 2021 | 122 | 2021 |
| Patient, surgeon, and hospital disparities associated with benign hysterectomy approach and perioperative complications A Mehta, T Xu, S Hutfless, MA Makary, AK Sinno, EJ Tanner III, RL Stone, ... American journal of obstetrics and gynecology 216 (5), 497. e1-497. e10, 2017 | 118 | 2017 |
| Management of uterine adenosarcomas with and without sarcomatous overgrowth EJ Tanner, T Toussaint, MM Leitao Jr, ML Hensley, RA Soslow, ... Gynecologic oncology 129 (1), 140-144, 2013 | 106 | 2013 |
| High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes EJ Tanner, K Garg, MM Leitao Jr, RA Soslow, ML Hensley Gynecologic oncology 127 (1), 27-31, 2012 | 102 | 2012 |
| A microRNA survival signature (MiSS) for advanced ovarian cancer KK Shih, LX Qin, EJ Tanner, Q Zhou, M Bisogna, F Dao, N Olvera, A Viale, ... Gynecologic oncology 121 (3), 444-450, 2011 | 96 | 2011 |
| Laparoscopy in the morbidly obese: physiologic considerations and surgical techniques to optimize success SA Scheib, E Tanner III, IC Green, AN Fader Journal of minimally invasive gynecology 21 (2), 182-195, 2014 | 95 | 2014 |
| Utilization of minimally invasive surgery in endometrial cancer care: a quality and cost disparity AN Fader, RM Weise, AK Sinno, EJ Tanner III, BJ Borah, JP Moriarty, ... Obstetrics & Gynecology 127 (1), 91-100, 2016 | 92 | 2016 |
| The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma EJ Tanner, MM Leitao Jr, K Garg, DS Chi, Y Sonoda, GJ Gardner, ... Gynecologic oncology 123 (3), 548-552, 2011 | 86 | 2011 |
| Surveillance for the detection of recurrent ovarian cancer: survival impact or lead-time bias? EJ Tanner, DS Chi, EL Eisenhauer, TP Diaz-Montes, A Santillan, ... Gynecologic oncology 117 (2), 336-340, 2010 | 82 | 2010 |
| Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival? AN Fader, J Bergstrom, A Jernigan, EJ Tanner III, KL Roche, RL Stone, ... Gynecologic oncology 147 (1), 85-91, 2017 | 81 | 2017 |
| Minimally invasive hysterectomy surgery rates for endometrial cancer performed at National Comprehensive Cancer Network (NCCN) Centers J Bergstrom, A Aloisi, S Armbruster, TT Yen, J Casarin, MM Leitao Jr, ... Gynecologic oncology 148 (3), 480-484, 2018 | 70 | 2018 |
| Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma? S Ricci, RL Giuntoli II, E Eisenhauer, MA Lopez, L Krill, EJ Tanner III, ... Gynecologic oncology 131 (3), 629-633, 2013 | 69 | 2013 |
Amanda Nickles FaderJohns HopkinsVerifierad e-postadress på jhmi.edu
